Clinical trial
MULTIMODALITY TREATMENT STRATEGY FOR STAGE III BREAST CANCER
NCT00002696 is registered in ClinicalTrials.gov with Grupo Oncologico Cooperativo del Sur as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MULTIMODALITY TREATMENT STRATEGY FOR STAGE III BREAST CANCER
- Lead sponsor
- Grupo Oncologico Cooperativo del Sur
- Phase
- Phase 3
- Overall status
- Suspended
- Start date
- October 31, 1995
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer